The value of coagulation factor V and VIIIIV levels as prognostic indicators was assessed in 27 patients with fulminant hepatic failure and compared with other predictive indices. Admission factor V levels were significantly reduced in 22 patients with paracetamol induced hepatic failure compared with a healthy control group (median 9*5% v 103%, respectively; p<0001) and with lower values in non-A non-B hepatitis (median 2.7%).
Values in the seven patients who died after paracetamol overdose, considered together with the four who underwent liver transplantation (group median 5-1%), were significantly lower than in the 11 who survived (median 11-8%; p<001). Median admission factor VIII was higher in those who died or received a transplant than in those who survived (298% v 162%; p<005), with both results higher than in healthy volunteers (median 104%; p<001) but lower than in non-A non-B hepatitis (median 340%). The ratio of factor VIIIIV on admission was <30 in all patients who survived paracetamol overdose (median 17) with corresponding values >30 in 10 of 11 of those who died (median 39). A factor V result -10% on admission predicted an adverse outcome in 10 of 11 fatal cases, a 91% sensitivity which was greater than for the previously defined indicator of an arterial blood pH <7*30 on admission (sensitivity 82%). Prothrombin time at admission or on day 4 did not usefully predict outcome in our series. Predictive accuracy was 73% and 82% for factor V and admission acidosis respectively and 95% for factor V in conjunction with admission coma grade III or IV and factor VIII (ratio >30). These criteria may be useful in selecting patients with paracetamol induced fulminant hepatic failure for transplantation.
In the United Kingdom paracetamol overdose is the most common Results Seven (32%) of the 22 patients with paracetamol induced fulminant hepatic failure died 3-15 days after admission with death due to cerebral oedema in three and persistent infection in four. A further four were referred for liver transplantation at two to five days because of a predicted poor prognosis (arterial blood pH <7.30)6 and these were considered with the seven fatal cases in the analysis of outcome. Four of the five patients with non-A non-B hepatitis died from cerebral oedema and sepsis (two to six days after admission) and the remaining patient underwent liver transplantation after two days using prognostic indicators of age over 40 years, serum bilirubin concentration >300 imol/l, and grade IV encephalopathy.
Factor V. Levels on admission in the 22 patients with paracetamol induced hepatic , and ratio VIIIIV (C) in 22 patients with paracetamol induced fulminant hepaticfailure in relation to outcome. There were significant differences between values in the 11 survivors and in the 11 patients who diedforfactor V (p<O 01), factor VIII (p<O05), and ratio factor VIIIIV (p<0 001). Normal ranges are presented in Table I. failure (median 9 5%; range 3 09-27-9%) were substantially lower than in the normal control subjects (median 103%; range 45-118%; p<0001). Values Admission factor V results in the five patients with non-A non-B fulminant viral hepatitis were the lowest recorded (median 2-7%; range 1-7-4K1%. Sequential factor V results in the paracetamol overdose patients who survived showed a return to the normal range within four days of admission. In those patients who died no significant change was observed, with mean values remaining below 17% at four days (Fig 2) . Trough factor V results in survivors were significantly higher than in patients who died (median 117% v 4 4%; p<001). Sequential factor V results continued to fall after admission in four of five patients with non-A non-B hepatitis.
Factor VIII and factor VIIIIV ratios. Median factor VIII on admission in paracetamol induced fulminant hepatic failure was higher in patients who died or received a transplant than in survivors (298% v 162%; p<005), (Fig IB; Table  I ). Both results were significantly higher than for the control group (median 104%; range 72-144%; p<0 01). Sequential factor VIII results fell consistently only in survivors, with peak factor VIII significantly lower than in those who died (median 233 v 335; p<0 01). In the five patients with non-A non-B hepatitis, factor VIII was again appreciably increased (median 340%, range 290-620%; p<0 01 v control), although not significantly higher than in the fatal paracetamol overdose cases. Using the ratio of factor VIIIV, there was greater discrimination between results in patients with paracetamol induced hepatic failure who died (median 39) and those who survived (median 17; p<0 001) (Fig IC; Table I ). Ten of 11 fatal cases showed a ratio >30 on admission. Sequential values for the ratio showed a steady fall in patients who survived but an increase in those who died. Admission ratios were even higher in the five patients with fulminant viral hepatitis (median 165, range 76-226; p<0 001 v control). In contrast to the paracetamol overdose cases, sequential factor VIII/V results decreased in these patients, even though four of the five patients died.
Of the additional laboratory variables determined on admission, only serum creatinine results differed significantly between patients who died and those who survived after paracetamol overdose (median 289 v 145 ,tmol/l, p<001; Table I ). There were no corresponding differences in the admission prothrombin time ratio (Table I) Table I ).
When compared to factor V -10%, which predicted death in 10 of the 11 fatal cases (91% sensitivity), acidosis on admission (pH <7 30) was observed in nine ofthese 11 (sensitivity 82%) (Fig 3A) . In neither of the two patients who died without systemic acidosis were the prognostic criteria of coma grade >II, prothrombin time >100 s, and serum creatinine >300 ,umol/l satisfied.'0 Thus the predictive sensitivity for an adverse outcome of a factor V result of c 10% on admission (91%) was the same as that of the two major prognostic indicators of O'Grady et al combined (91%) ( Table II) . It was greater than for the predictive sensitivity of 20% for a prothrombin time on day 4 of >180 s.18 Five of 11 survivors had a factor V result of c 10% (55% specificity) but this specificity and the corresponding positive predictive value increased substantially (both to 91%) when an admission factor V result of < 10% was taken in conjunction with grade III or IV encephalopathy. These results were greater than the corresponding specificity and positive predictive value for admission pH <7 30 (both 82%). The sensitivity for a poor prognosis of an admission factor VIII/ V ratio of >30 was the same as factor V 10% (91%) and this ratio showed the greatest accuracy in correctly predicting outcome in 21 of 22 cases (95%) compared with values for admission factor V -10% (73%) or admission pH <7 30 (82%) ( Table II) . No false positive results were observed using the indicator factor VIIINV ratio >30 (positive predictive value= 100%), although a corresponding frequency of 5/15 was seen for an admission factor V level of < 10% (positive predictive value=67%).
Discussion
Plasma factor V concentrations were not only substantially reduced when the patients were admitted to the unit (usually during the second day after the paracetamol overdose), but values of < 10% also showed a high sensitivity for predicting an adverse outcome. This rapid diminution of factor V levels probably reflects the decrease over two to three half-lives (12-24 hours each) with synthesis largely inhibited as a result of the rapidly developing liver damage. Substantial decreases have also been shown in such cases for other clotting factors synthesised in the liver including factor VII,'9 protein C,20 and antithrombin III.2" A prolonged inhibition of factor V synthesis was also a poor prognostic sign, with factor V levels remaining below 17% The shorter duration ofonset ofhepatic failure after paracetamol overdose than after non-A non-B viral hepatitis may explain the less pronounced rises in factor VIII concentrations and factor VIII:V ratio we observed at admission in the former group. This may be a result of poor clearance due to suppressed reticuloendothelial function, continued extrahepatic synthesis of factor VIII, or reduced hepatic synthesis of protein C, a potent inhibitor of activated factor VIII.'5 Factor VIII:V ratios have not been used before as a predictor of outcome but their value may derive partly from detecting high factor VIII concentrations released when vascular endothelial cells are damaged. Taken together with low factor V concentrations reflecting decreased hepatic synthetic function, factor VIII:V ratios may give a composite assessment of liver function that is reflected in their power for correctly predicting outcome in 95% of the cases in this series.
Both factor V and factor VIII can be readily measured in any laboratory performing coagulation tests, and a result can be available within five minutes of obtaining a plasma sample. After paracetamol overdose, a plasma factor V concentration of -10% of normal should be taken as a poor prognostic sign. In conjunction with a substantial increase in factor VIII (factor VIIINV ratio >30) or severe hepatic coma within two or three days of overdose, factor V levels of . 10% seem valuable in selecting such patients for transplantation, but this requires confirmation in a large series.
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